See more : Algonquin Power & Utilities Cor (AQNB) Income Statement Analysis – Financial Results
Complete financial analysis of PT Nanotech Indonesia Global Tbk (NANO.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Nanotech Indonesia Global Tbk, a leading company in the Medical – Devices industry within the Healthcare sector.
- Puequ CO.,LTD. (9264.T) Income Statement Analysis – Financial Results
- Bukit Jalil Global Acquisition 1 Ltd (BUJAR) Income Statement Analysis – Financial Results
- BioInvent International AB (publ) (BOVNF) Income Statement Analysis – Financial Results
- China Shineway Pharmaceutical Group Limited (2877.HK) Income Statement Analysis – Financial Results
- Koninklijke KPN N.V. (KPN.AS) Income Statement Analysis – Financial Results
PT Nanotech Indonesia Global Tbk (NANO.JK)
About PT Nanotech Indonesia Global Tbk
PT Nanotech Indonesia Global Tbk, a tech company, engages in the field of research and development (R&D)-based and technology-based technology services, materials engineering, and nanotechnology. The company operates in the materials, health, aquaculture, inspection, property, and education businesses. It provides R&D, engineering, supplier services equipment and materials nano, and human resource capacity building services. The company was founded in 2005 and is based in South Tangerang, Indonesia. PT Nanotech Indonesia Global Tbk is a subsidiary of PT Nanotech Investama Sedaya.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 83.82B | 44.70B | 26.77B | 16.04B | 8.07B |
| Cost of Revenue | 61.15B | 27.31B | 17.23B | 6.77B | 3.69B |
| Gross Profit | 22.67B | 17.40B | 9.55B | 9.27B | 4.37B |
| Gross Profit Ratio | 27.04% | 38.92% | 35.66% | 57.76% | 54.21% |
| Research & Development | 310.56M | 367.80M | 1.75B | 0.00 | 0.00 |
| General & Administrative | 15.39B | 12.32B | 5.50B | 3.17B | 2.54B |
| Selling & Marketing | 4.99B | 1.93B | 1.68B | 839.18M | 193.05M |
| SG&A | 20.82B | 14.52B | 6.28B | 3.39B | 2.79B |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 21.13B | 14.52B | 6.28B | 3.39B | 2.80B |
| Cost & Expenses | 82.29B | 41.83B | 23.50B | 10.17B | 6.50B |
| Interest Income | 1.71B | 498.74M | 56.44M | 25.41M | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 3.35B | 2.93B | 1.49B | 148.08M | 39.96M |
| EBITDA | 5.20B | 5.99B | 3.63B | 5.01B | 1.59B |
| EBITDA Ratio | 6.20% | 12.99% | 17.79% | 37.53% | 19.66% |
| Operating Income | 1.54B | 2.88B | 3.27B | 5.87B | 1.55B |
| Operating Income Ratio | 1.83% | 6.43% | 12.21% | 36.60% | 19.16% |
| Total Other Income/Expenses | -274.76M | -705.78M | -1.08B | -781.34M | 26.55M |
| Income Before Tax | 1.26B | 2.17B | 2.19B | 5.09B | 1.57B |
| Income Before Tax Ratio | 1.50% | 4.85% | 8.19% | 31.73% | 19.49% |
| Income Tax Expense | 472.38M | 454.04M | 401.35M | -22.20M | 0.00 |
| Net Income | 1.35B | 1.67B | 1.24B | 2.62B | 1.57B |
| Net Income Ratio | 1.62% | 3.75% | 4.63% | 16.32% | 19.49% |
| EPS | 0.32 | 0.39 | 0.29 | 0.61 | 1.57 |
| EPS Diluted | 0.32 | 0.39 | 0.29 | 0.61 | 1.57 |
| Weighted Avg Shares Out | 4.29B | 4.29B | 4.29B | 4.29B | 1.00B |
| Weighted Avg Shares Out (Dil) | 4.29B | 4.29B | 4.29B | 4.29B | 1.00B |
Source: https://incomestatements.info
Category: Stock Reports